Ethical Compliance
NGL FINE CHEM
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Market Cap Class:
small
Revenue
3%
Debt
9.1%
Liquidity
0.5%
Revenue
Debt
Liquidity
3%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Pharmaceuticals | ₹333.54 |
| Sale of services | ₹0.17 |
| Other Operating Income | ₹4.98 |
| Other Income | ₹3.50 |
Questionable
INR Crores
| Net Gain on Sale of Investments | ₹10.03 |
Non Compliant
INR Crores
| Interest income | ₹0.60 |
INR Crores
| Revenue from Questionable Sources: | ₹10.03 |
| Revenue from Non Compliant Sources: | ₹0.60 |
| Total: | ₹10.63 |
| Total Revenue: | ₹352.82 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹10.63
₹352.82
= 3%
questionable
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
